Fatty Acid Metabolism Flashcards

1
Q

Significance of Fatty Acids

A
  • Most lipids contain or are derived from fatty acids.
  • Structural components of:
    • Triacylglycerols (TAG) aka triglycerides (TG)
      • 3 FA esterified to a glycerol backbone
    • Phospholipids (PL)
      • 2 FA esterified to phosphorylated glycerol
    • Glycolipids (GL)
      • 1 FA linked to a glycosylated ceramide
    • Cholesteryl ester (CE)
      • 1 FA esterified to steroid ring of cholesterol
  • Precursors in the synthesis of eicosanoids
    • Prostaglandins
    • Thromboxanes
    • Leukotrienes
  • Synthesized from acetyl CoA
  • Catabolized to acetyl CoA
  • Disturbed in a number of pathological processes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Fatty Acid Structure

A
  • Carboxylic acid group (COO-) ⇒ C#1
    • C#2 ⇒ α, C#3 ⇒ β
  • Alkyl chain, typically:
    • Linear (unbranched)
    • Methyl (-CH3) terminus ⇒ ω-carbon
    • Even # of carbons
    • Long
      • SCFA: 2-4 C
      • MCFA: 6-12 C
      • LCFA: 14-20 C
      • VLCFA: ≥ 22 C
  • If unsaturated:
    • Monounsaturated (MUFA) ⇒ 1 C=C
    • Polyunsaturated (PUFA) ⇒ 2 or more C=C
      • In cis configuration
      • At 3 carbon intervals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Palmitic Acid

A

IUPAC: Hexadecanoic acid

Carboxyl-Reference: 16:0

Omega (ω) - reference: 16:0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Palmitoleic Acid

A

IUPAC: 9-hexadecenoic acid

Carboxyl-Reference: 16:1Δ9

Omega (ω) - reference: 16:1 (ω-7) or (n-7)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Stearic Acid

A

IUPAC: octadecanoic acid

Carboxyl-Reference: 18:0

Omega (ω) - reference: 18:0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Oleic Acid

A

IUPAC: 9-octadecenoic acid

Carboxyl-Reference: 18:1∆9

Omega (ω) - reference: 18:1 (ω - 9) or (n - 9)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Linoleic Acid

A

IUPAC: 9,12-octadecadienoic acid

Carboxyl-Reference: 18:2∆9,12

Omega (ω) - reference: 18:2 (ω - 6) or (n - 6)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

α-linolenic Acid

A

IUPAC: 9,12,15-octadecatrienoic acid

Carboxyl-Reference: 18:3∆9,12,15

Omega (ω) - reference: 18:3 (ω - 3) or (n - 3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Arachidonic Acid

A

IUPAC: 5,8,11,14-eicosatetraenoic acid

Carboxyl-Reference: 20:4∆5,8,11,14

Omega (ω) - reference: 20:4 (ω - 6) or (n - 6)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Fatty Acid Synthesis Overview

A

In humans the overall reaction is:

8 Acetyl Co-A + 7 ATP + 14 (NADPH+H+)

Palmitate (16:0) + 8 CoA​ + 7 (ADP + PI) + 14 NADP+ + 6 H2O

  • Cytosolic process especially important in the liver, CNS, lactating mammary gland, and adipose tissue
  • Endergonic and reductive
  • Acetyl-CoA from glycolysis and PDH reaction
  • NADPH from pentose phosphate pathway and malic enzyme
  • Catalyzed by two enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Citrate Shuttle

A

Acetyl CoA is generated in the mitochondrial matrix (by glycolysis and PDH complex) but fatty acid synthesis occurs in the cytosol.

CoA cannot cross the inner mitochondrial membrane.

Acetate transported out as citrate without the crossing of CoA.

  1. Acetyl CoA is combined with oxaloacetate in the mitochondrial matrix to form citrate by citrate synthase with the release of CoA.
    • Glucose breakdown inhibited in the liver during times of excess energy ⇒ High [ATP] inhibits Isocitrate dehydrogenase of TCA cycle. Isocitrate easily interconverted to citrate.
  2. Citrate transported out of the mitochondria to the cytosol where it is converted by citrate lyase + CoA into Citrate-CoA.
  3. Citrate CoA cleaved by citrate cleavage enzyme with use of 1 ATP back into Acetyl CoA and Oxaloacetate.
    • Enzyme positively regulated in response to insulin.
  4. Acetyl CoA used in FA synthesis.
  5. Oxaloacetate converted to Malate by Malate Dehydrogenase with the use of 1 NADH.
  6. Malate can either:
    • Return to the mitochondria via the malate shuttle.
      • Be converted in the matrix back to oxaloacetate by malate dehydrogenase with the production of 1 NADH.
    • Be converted in the cytosol to Pyruvate by Malic Enzyme releasing CO2 and producing 1 NADPH
      • Another source for NADPH used in FA synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Coenzyme A

A
  • Often-used carrier of activated acyl groups
    • Acetyl
    • Fatty acyl
    • Others
  • Thioester linkage has a large negative ΔG°’ of hydrolysis of -7.5 kcal/mol
  • Phosphopantetheine group acts as a long arm which shuttles substrates similar to E2 of PDH & α-KGD complexes
    • Contains pantothenic acid (Vit B5)
      • Not synthesized in humans so it is an essential nutrient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Fatty Acid Synthesis

Part 1

A

Acetyl CoA (2C) + Carbon Dioxide (form of HCO3-) + ATP

Malonyl CoA (3C)

Catalyzed by acetyl CoA carboxylase (ACC)

  • Committed and rate-liming step of FA biosynthesis
  • Irreversible reaction
  • ACC affected by allosteric and covalent regulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Acetyl CoA Carboxylase

(ACC)

A
  • Rate-limiting enzyme of fatty acid biosynthesis
  • Requires biotin coenzyme
    • Shuttles CO2 to acceptors
    • Swinging arm mechanism
  • Short-term regulation
    • Allosteric Effectors
      • Pos: citrate
      • Neg: end product ⇒ palmatate in humans
    • Covalent Regulation
      • Activated: dephosphorylation
      • Inactivated: phosphorylation
        • By AMP-activated protein kinase (AMPK) or PKA
        • AMPK allosterically activated in response to an increase in AMP/ATP ratio such as with hypoxia, exercise, etc.
        • So when [ATP] low FA biosynthesis is not attempted because ACC requires ATP
    • Citrate + dephosphorylation favors the polymerization of the protein into the active form.
  • Long-term regulation via gene expression
    • Diet controlled:
      • High carb diet increases expression of ACC via trans-acting ChREBP at cis-acting ChoRE.
      • High fat diet decreases transcription.
    • Hormone controlled:
      • Insulin increases ACC expression via trans-acting SREBP (Sterol Regulatory Element Binding Protein)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fatty Acid Synthesis

Part 2

A

Adds 2C’s from malonyl CoA to the carboxylate end of an acyl acceptor through a repetitive 4-step sequence:

  1. Condensation (decarboxylation)
  2. Reduction (requires NADPH)
  3. Dehydration
  4. Reduction (requires NADPH)

Catalyzed by a single homodimeric multifunctional protein

Fatty Acid Synthase (FAS)

6 catalytic activities + 1 acyl carrier protein (ACP) domain

ACP domain contains phosphopantetheine group (as seen in CoA) which acts as a swinging arm between catalytic domains.

  1. The initial acyl acceptor, Acetyl CoA (2C), is loaded onto the ACP domain of FAS then transferred to a cys residue in the condensing enzyme domain (CE) via the transacylase activity (#1) releasing CoA.
  2. Malonyl CoA (3C) previously formed by ACC is transferred to the ACP domain via the transacylase activity releasing CoA.
  3. Condensation reaction involves condensation of malonyl and acetate releasing the CO2 which was previously added by ACC (decarboxylation) catalyzed by the β-ketoacyl ACP synthase (KS) domain aka condensing enzyme (#2).
  4. First reduction of the keto-group by β-ketoacyl ACP reductase (KR) activity (#3) requiring 1 NADPH yields a hydroxyl.
  5. The D-isomer hydroxyl is dehydrated by β-hydroxyacyl ACP dehydratase (DH) activity (#4) to yield a trans-double bond.
  6. Second reduction of the trans-double bond by trans-enoyl ACP reductase (ER) activity (#5) requiring 1 NADPH yields butyryl (4C).
  7. Butyrl acts as the next acyl acceptor and the cycle repeats adding 2 C’s from malonyl CoA each time.
  8. After 8 total cycles yielding palmitate (16C) the active site is not able to accomodate anything larger and the fatty acid is cleaved from the ACP domain by the thioesterase activity (TE) (#6).
  • The terminal two carbons of palmitate are from acetyl CoA and the rest are from malonyl CoA.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fatty Acid Synthase

Regulation

A
  • No short term regulation
  • Long-term control by transcriptional regulation
    • Expression increases with high carb diet
    • Expression decreases with high fat diet
    • Elevated [glucose]blood causes increase in [insulin] resulting in increased expression of FAS
      • Also ACC, malic enzyme, and G6PD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Elongation of

Dietary and Endogenous Fatty Acids

A
  • Occurs in the SER and mitochondria
  • Mechanistically similar to de novo synthesis of FA ⇒ 2C’s from malonyl CoA added at a time to the carboxylate end
  • Differences:
    • More than 1 enzyme involved ⇒ elongase system
    • Enzymes are mostly ER-membrane proteins
    • CoA esters are used to move the substrate instead of ACP
    • Substrates of ≥ 10C’s
    • Product is typically 18C
18
Q

Desaturation of

Dietary and Endogenous Fatty Acids

A
  • Insertion of a C=C
  • Occurs in the SER
  • Fatty acid and NADH both get oxidized as O2 is reduced to 2 H2O
  • Involves:
    • Desaturases
    • Cytochrome B5
    • NADH-cytochrome B5 reductase flavo-protein (FAD containing) located in the ER membrane
  • Humans have four desaturases: Δ9, Δ6, Δ5, Δ4
    • Cannot insert C=C between C10 and ω-C
    • Substrates primarily ≥ 18C
    • 18:1Δ9 is the most common
19
Q

Generation of Arachidonic Acid

A

Elongation Paired with Desaturation of Dietary FA

  • Humans unable to make ω-6 or ω-3 unsaturated FA, however, they are dietary essential nutrients for the production of other PUFA such as arachidonic acid
    • Precursor of eicosanoid hormones
  1. Linoleic acid (18:2Δ9,12) taken in by diet
  2. Undergoes Δ6 desaturation to form 18:3Δ6,9,12
  3. Elongated to form 20:3Δ8,11,14
    • C=C are pushced back by addition of 2C to the carboxylate end
  4. Undergoes Δ5 desaturation to form 20:4Δ5,8,11,14 (arachidonate)

There is no interconversions between families ⇒ ω-6 family was unchanged after elongation and desaturation.

20
Q

Storage of Fatty Acids

A
  • FA stored as triglycerides/triacylglycerols (TAG)
    • Composed of 3 FA esterified to glycerol
  • TAG stored within a single large anhydrous droplet coated with a monolayer containing:
    • Phospholipids
    • Cholesterol
    • Proteins such as perilipin
  • More efficient form of stoerage compared to glycogen
  • TAG synthesized primarily in the liver from glucose
    • Sent out into the blood as VLDL
    • Stored primarily in adipocytes of white adipose tissue
21
Q

Retrieval of Fatty Acids

A
  • Triglycerides stored in adipose tissue degraded to fatty acids x 3 plus glycerol by adipose lipases
    • Hormone-sensitive lipase
      • Phosphorylated and activated by PKA in response to catecholamines primarily
    • Phosphorylation of perilipin by PKA allows P-HSL to bind to P-perilipin on the lipid droplet
  1. Glycerol can be used by the liver for gluconeogenesis.
  2. Fatty acids carried in the blood on albumin, picked up by muscle and liver, activated, and oxidized to acetyl CoA and ultimately to CO2 in mitochondria providing significants amount of ATP.
    • ATP and NADH used for gluconeogenesis in liver
    • Used in muscles to spare glucose for glucose-dependent tissues
  3. During prolonged fasting, 80% of energy is supplied by lipolysis.
22
Q

Fatty Acid

Activation

A
  • Activation involves formation of CoA esters and is required for FA participation in metabolism.
  • SCFA and MCFA able to enter the matrix and activated there.
  • Catalyzed by fatty acyl-CoA synthetases
    • Requires ATP and CoA
    • Enzyme produces PPi which is hydrolyzed to 2 Pi which drives the reaction forward.
  • Family of synthetases based on chain length:
    • SCFA/MCFA in mitochondrial matrix
    • LCFA synthetases in the outer mitochondrial membrane but faces the cytosol, in SER, and peroxisomes.
    • VLCFA in peroxisomal membrane only
23
Q

Carnitine Shuttle

A
  • LCFA are activated in the cytosol but oxidation occurs in the mitochondrial matrix.
  • CoA unable to cross the inner membrane.
  • FA attached to carnitine in order to facilitate transport.
    • Carnitine is made from lys in the liver and kidney primarily.

For long chain fatty acids:

  1. FA attached to CoA by acyl CoA synthetase located on the outer mitochondrial membrane.
  2. Fatty acyl CoA able to cross the outer mitochondrial membrane.
  3. In the intermembrane space, fatty acyl group transferred from CoA to carnitine by Carnitine palmitoyl-transferase I (CPT-I) aka carnitine acyltransferase (CAT-I)
    • ​​Rate-limiting and regulated enzyme of LCFA oxidation.
    • Inhibited by malonyl CoA ⇒ made by ACC2 in mitochondria of skeletal muscle, cardiac muscle, and liver with sole purpose to regulatE CPT I
  4. Fatty acyl-carnitine passes through the inner mitochondrial membrane via the carnitine acylcarnitine translocase.
  5. In the matrix, fatty acyl group transferred to mitochondrial CoA by CPT II.
24
Q

Deficiencies in Carnitine System

A
  • Rare deficiencies of CPT-I, CPT-II, and translocase
  • Carnitine deficiency
    • decreased synthesis (premature babies)
    • defect in membrane transporter in muscle, heart, kidney
    • Severity varies
    • Treatment:
      • Avoidance of fasting
      • Diet low in LCFA
      • dietary supplementation wtih MCTG and carnitine
25
Q

Mitochondrial β-oxidation

Overview

A

For long unbranched saturated even C fatty acids.

  • Occurs in the mitochondrial matrix
  • Oxidative
    • Requires FAD and NAD+
  • Exergonic
  • Remove 2C fragments from carboxylate-end forming acetyl CoA
  • Repetitive process
    • Dehydrogenation (FAD)
    • Hydration
    • Dehydrogenation (NAD+)
    • Thiolysis
  • Key regulated enzyme
    • CPT I
      • Inhibited by malonyl CoA
26
Q

Fatty Acid β-oxidation

Mechanism

A

Repetitive four-step sequence of reactions.

  1. First dehydrogenation of the fatty-acyl CoA catalyzed by chain-length specific acyl CoA dehydrogenases using FAD forms an enoyl CoA with trans double bond between C2 and C3 (α and β carbons) and generates FADH2.
  2. Hydration of the trans Δ2-enol CoA by enoyl CoA hydratases adds water across the double bond to form β-hydroxyacyl CoA.
  3. Second dehydrogenation of the β-hydroxyacyl CoA by β-hydroxyacyl CoA dehydrogenase using NAD oxidizes the hydroxyl group at the β-carbon to a keto group forming a β-ketoacyl CoA.
  4. Thiolytic cleavage between the α and β carbons by β-ketoacyl CoA thiolase using CoA releases Acetyl CoA from the carboxy-terminus leaving a fatty acyln-2C CoA
  5. Cycle is repeated until the entire FA is degraded into acetyl CoA fragments.

For LCFA only, steps 2-4 are catalyzed by mitochondrial trifunctional protein (TFP).

27
Q

Fates of products of β-oxidation

A
  • Acetyl CoA
    • Oxidized in the TCA cycle: CO2, FADH2, NADH, and GTP are produced
    • Used for ketogenesis in liver
  • FADH2
    • Oxidized by ETC at CoQ for ATP synthesis
  • NADH
    • Oxidized by ETC at Complex I for ATP synthesis
  • NADH and ATP can be used in gluconeogenesis by the liver
28
Q

Regulation of β-oxidation

A
  • Substrate availability
    • as [substrates] increase β-oxidation increases
  • Malonyl CoA availability
    • as [malonyl CoA] decreases β-oxidation increases
      • Because malonyl CoA inhibits CAT-1
  • Acetyl CoA/CoA ratio
    • as ratio increases, β-oxidation decreases
      • Due to decreased thiolase activity becauses needs free CoA to continue
  • In liver, acetyl CoA also allosterically activates pyruvate carboxylase of gluconeogenesis ⇒ tells liver its time to make glucose.
  • In muscle, acetyl CoA increases citrate concentration which inhibits glycolysis at PFK-1, conserving glucose.
29
Q

Overview of Fatty Acid Metabolism

A
30
Q

ATP Yield From β-oxidation of Palmitate

A

7 FADH2 x 2 ATP/FADH2 = 14 ATP

7 NADH x 3 ATP/NADH = 21 ATP

8 Acetyl CoA: If completely oxidized through the ETC

24 NADH x 3 ATP/NADH = 72 ATP

8 FADH2 x 2 ATP/FADH2 = 16 ATP

8 GTP = 8 ATP

= 131 ATP

Cost of activation - 2 ATP

About 130 ATP per molecule of Palmatate or 8 ATP / carbon

31
Q

β-oxidation

Odd-numbered fatty acids

A

Odd # FA from exogenous sources oxidized for energy.

3C product at the end.

Requires additional enzymes.

  1. Propionyl CoA (3C) converted to L-methylmalonyl CoA by propionyl CoA carboxylase via the addition of a carbon dioxide in the form of HCO3- to the α-carbon.
    • Enzyme requires biotin and ATP
    • Third carboxylase encountered
  2. L-methylmalonyl CoA converted to succinyl CoA by methylmalonyl CoA mutase
    • Enzyme requires Vit B12 coenzyme.
  3. Succinyl CoA can:
    • Enter the TCA cycle ⇒ Anaplerotic reaction
    • OR BE USED IN THE LIVER TO MAKE GLUCOSE!!!
      • Only time you can make glucose from FA is with propionyl to succinyl CoA!!!
32
Q

β-oxidation

Unsaturated Fatty Acids

A

Problem:

Intermediate formed is not a substrate for the enoyl hydratase which requires a trans Δ2 double bond.

Solution:

Use additional enzymes to convert the product into an acceptable substrate.

Double bonds at odd-numbered C requires 3,2-enoyl CoA Isomerase.

Double bond at even-numbered C requires 2,4-dienoyl CoA reductase.

Energy yield for unsaturated FA less that saturated FA because fewer H’s.

33
Q

β-oxidation

Very Long Chain Fatty Acids

A
  • Peroxisomes required for β-oxidation of VLCFA.
    • Only peroxisomes have fatty acyl CoA synthetases for FA ≥ 24 C.
  • Transport into peroxisomes uses an ABC transporter instead of carnitine.
  • Repetitive 4-step process similar to mitochondrial β-oxidation results in chain shortening to MCFA.
    • First enzyme is a flavin oxidase which uses O2 as the electron acceptor producing H2O2
    • OK because peroxisomes have catalase
    • Less energy yield because FAHD2 is not produced
  • Oxidation process stops at MCFA
  • MCFA then linked to carnitine (not CoA because peroxisomes don’t have ETC enzymes)
  • MCFA-carnitine complex travel to the mitochondria where they are oxidized into acetyl CoA
34
Q

X-linked Adrenoleukodystrophy

(X-ALD)

A
  • Rare disorder of peroxisomal VLCFA β-oxidation
  • Due to defect in the ABCD1 transporter which brings VLCFA into the peroxisomes.
  • Results in the accumulation of VLCFA especially in the brain and adrenals
  • Childhood and adult forms
  • Childhood cerebral form
    • Boy develops normally until school age (~ 7 y/o)
    • Shows dementia
    • Progressive neurological loss to a vegetative state
    • Adrenal insufficiency
    • Typically fatal by age 10
35
Q

Peroxisomal α-oxidation of fatty acids

A
  • Occurs at the α-carbon instead of the β-C
  • Shortens FA by 1C
  • Important in the oxidation of branched-chain phytanic acid ⇒ 20C product of chlorophyll degradation
    • Methyl group on C3 of phytanic acid prevents β-oxidation
  • 4-step process results in the hydroxylation of C2 of BCFA with release of C1 as CO2
    • Enzyme #2: α-hydroxylase is a site of pathology
    • Generates pristanic acid which gets activated and undergoes β-oxidation
36
Q

Refsum Disease

A
  • Phytanic acid storage disease
  • Autosomal recessive
  • Due to deficiency of the α-hydroxylase enzyme involved in peroxisomal α-oxidation of branched chain FA
  • Symptoms first seen in teens
  • Full progression can take 30 years
  • Treatment: dietary restriction of phytanic acid
37
Q

Ketone Bodies

Structure & Function

A
  • 4C water-soluble organic acids
    • PKa ~ 3.5 so easily ionizes in plasma leading to acidosis
  • Made primarily by the liver from acetyl CoA
  • Used by peripheral tissues to generate acetyl CoA and ultimately ATP
  • Very important for the brain during fasting because can easily cross the blood brain barrier
  • Ketone bodies are not linked to CoA so easily leaves the mitochondria after production.
38
Q

Ketogenesis

A

Synthesis of ketone bodies.

Occurs in mitochondria of hepatocytes.

Driven by [acetyl CoA].

  1. 2 Acetyl CoA condensed to form acetoacetyl CoA (4C) by thiolase with the release of a CoA.
  2. Acetoacetyl CoA (4C) condensed with another acetyl CoA (2C) to form β-hyroxyl-β-methylglutaryl CoA (HMG CoA - 6C) by HMG-CoA Synthase releasing another CoA.
  3. HMG CoA is cleaved by HMG-CoA lyase to acetoacetate (4C) releasing an acetyl CoA.
  4. Acetoacetate can:
    • Be converted to β-hyroxybutyrate by β-hyroxybutyrate dehydrogenase with concominant conversion of NADH to NAD+​.
    • Undergo spontaneous decarboxylation to acetone + CO2
      • Metabolic dead end
      • Acetone excreted in the breath (& urine) and can be used as a diagnostic measure of DKA

Ketone bodies readily exit the mitochondria after production.

Presence of HMG-CoA lyase in the liver allows production of ketone bodies.

Release of CoA supports continued β-oxidation.

High availability of NADH from β-oxidation pushes acetoacetate to β-hydroxybutyrate.

39
Q

Ketolysis

A
  • Catabolism and utilization of ketone bodies for energy
  • Occurs in mitochondria of nonhepatic tissues (esp brain)
  • Liver lacks acetoacetate:succinyl CoA transferase so unable to use KB for energy
  1. β-OH-butyrateacetoacetate while NAD+ → NADH + H+
    by β-hydroxybutyrate dehydrogenase
  2. Acetoacetateacetoacetyl CoA while Succinyl-CoA → Succinate
    by acetoacetate:succinyl-CoA CoA transferase (Thiophorase)
    • ​​Acetoacetyl CoA trapped in the mitochondria
  3. Acetoacetyl CoA + CoA ⇔ 2 Acetyl CoA
    by Thiolase
  4. Acetyl CoA → TCA cycle → ATP
40
Q

Ketone Body Pathologies

A
  • Defects in ketogenesis
    • Caused by deficiency of mitochondrial HMG CoA synthase or lyase
    • Results in hpoketotic hypoglycemia
  • Defects in ketolysis
    • Due to deficiency in transferase
    • Results in ketoacidosis
41
Q

Medium chain acyl-CoA dehydrogenase

(MCAD) deficiency

A

Fasting Provoked Hypoketotic Hypoglycemia

  • Most common defect in mitochondrial FA β-oxidation
  • Autosomal recessive
    • Single missense mutation cause more than 90% of cases
  • A disorder of fasting adaptation
    • β-oxidation of FA ≤ 12 C is greatly reduced
    • Insufficient ketogenesis → hypoketosis
    • Hypoglycemia due to:
      • increased use of glucose in the absence of ketones as an alternate fuel
      • decreased production of glucose due to increased acetyl CoA suppression of glyconeogenesis
  • MCFA are pushed to the alternate path of ω-oxidation in the ER
    • Involves hydroxylation of ωC followed by oxidation to form a carboxyl group at the ω end producing medium-chain dicarboxylic acids
    • Up-regulation of this “rescue” path is a red flag
  • Treatment:
    • Avoid fasting
    • IV glucose in acute episode
    • Carnitine supplementation to aid in excretion of metabolites
    • Newborn screening